H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report)’s stock price dropped 49.5% during trading on Monday . The stock traded as low as $2.02 and last traded at $2.02. Approximately 400 shares changed hands during mid-day trading, an increase of 288% from the average daily volume of 103 shares. The stock had previously closed at $4.00.
H-CYTE Trading Down 49.5 %
The company’s 50-day simple moving average is $2.02 and its 200-day simple moving average is $2.02.
H-CYTE Company Profile
H-CYTE, Inc, a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease.
Featured Stories
- Five stocks we like better than H-CYTE
- What Are Dividend Contenders? Investing in Dividend Contenders
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- How to Use the MarketBeat Dividend Calculator
- Merger or Not, Albertson’s Companies is a Good Buy
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for H-CYTE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H-CYTE and related companies with MarketBeat.com's FREE daily email newsletter.
